PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism

PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism

Context: Hypoparathyroidism is characterized by insufficient levels of parathyroid hormone (PTH). TransCon PTH is an investigational long-Acting prodrug of PTH(1-34) for the treatment of hypoparathyroidism. Objective: This work aimed to investigate the safety, tolerability, and efficacy of daily Tra...

Olles dieđut

Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkkit: Aliya Khan, Lars Rejnmark, Mishaela R. Rubin, Peter Schwarz, Tamara Vokes, B.L. Clarke, Intekhab Ahmed, Lorenz C. Hofbauer, Claudio Marcocci, Uberto Pagotto, Andrea Palermo, Erik Fink Eriksen, Meryl Brod, Denka Markova, Alden Smith, Susanne Pihl, Sanchita Mourya, David Karpf, Aimee Shu
Materiálatiipa: Artigo
Giella:eaŋgalasgiella
Almmustuhtton: 2021
Liŋkkat:https://doi.org/10.1210/clinem/dgab577
https://academic.oup.com/jcem/article-pdf/107/1/e372/41819574/dgab577.pdf
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Interneahtta

https://doi.org/10.1210/clinem/dgab577
https://academic.oup.com/jcem/article-pdf/107/1/e372/41819574/dgab577.pdf

Geahča maid